INVESTOR ALERT: Investigation of Trinity Biotech plc Announced by Law Offices of Howard G. Smith
October 06 2016 - 5:24PM
Business Wire
Law Offices of Howard G. Smith announces an investigation
on behalf of investors of Trinity Biotech plc (“Trinity” or the
“Company”) (NASDAQ: TRIB) concerning the Company and its officers’
possible violations of federal securities laws.
Trinity acquires, develops, manufactures and markets medical
diagnostic products for the clinical laboratory and point-of-care
(POC) segments of the diagnostic market.
The investigation concerns Trinity’s October 4, 2016
announcement that the Company was withdrawing its 510(k) premarket
notification submission for the Meritas Troponin-I Test and Meritas
Point-of-Care Analyzer on the recommendation of the U.S. Food and
Drug Administration. On news of the withdrawal, Trinity’s share
price fell over 50% to close at just $6.46 per share on October 4,
2016, thereby injuring investors.
If you purchased Trinity securities, have information or would
like to learn more about these claims, or have any questions
concerning this announcement or your rights or interests with
respect to these matters, please contact Howard G. Smith, Esquire,
of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112,
Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847,
toll-free at (888) 638-4847, or by email
to howardsmith@howardsmithlaw.com, or visit our website at
http://www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in
some jurisdictions under the applicable law and ethical rules.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161006006491/en/
Law Offices of Howard G. SmithHoward G. Smith,
Esquire215-638-4847888-638-4847howardsmith@howardsmithlaw.comwww.howardsmithlaw.com
Trinity Biotech (NASDAQ:TRIB)
Historical Stock Chart
From Mar 2024 to Apr 2024
Trinity Biotech (NASDAQ:TRIB)
Historical Stock Chart
From Apr 2023 to Apr 2024